Vivo Opportunity, LLC, Director, Ten Percent Owner at Sierra Oncology, holds 6.29M shares in Soleno Therapeutics (Ticker: SLNO), holds 6.24M shares in Terns Pharmaceuticals (Ticker: TERN), holds 0.00 shares in Sierra Oncology (Ticker: SRRA). Most recently, Vivo Opportunity, LLC Sold ― shares of Soleno Therapeutics on Aug 29, 2024 for an estimated value of 49.21M.
What is the percentage of profitable transactions made by Vivo Opportunity, LLC?
The percentage of profitable transactions made by Vivo Opportunity, LLC is 83%.
What is the average return per transaction made by Vivo Opportunity, LLC?
The average return per transaction made by Vivo Opportunity, LLC is 31.10%.
What stocks does Vivo Opportunity, LLC hold?
Vivo Opportunity, LLC holds: SRRA, TERN, SLNO stocks.
What was Vivo Opportunity, LLC’s latest transaction?
Vivo Opportunity, LLC latest transaction was an Informative Sell of $49.21M.
What was Vivo Opportunity, LLC's most profitable transaction?
Vivo Opportunity, LLC’s most profitable transaction was an Informative Buy of SLNO stock on October 4, 2023. The return on the trade was 87.30%.
What is Vivo Opportunity, LLC's role in Sierra Oncology?
Vivo Opportunity, LLC's role in Sierra Oncology is Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.